167 related articles for article (PubMed ID: 15190299)
21. Dose-intensified treatment of advanced-stage diffuse large B-cell lymphomas.
Held G; Schubert J; Reiser M; Pfreundschuh M;
Semin Hematol; 2006 Oct; 43(4):221-9. PubMed ID: 17027656
[TBL] [Abstract][Full Text] [Related]
22. Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients.
Zinzani PL; Pellegrini C; Derenzini E; Argnani L; Pileri S
Hematol Oncol; 2013 Dec; 31(4):223-4. PubMed ID: 23620452
[No Abstract] [Full Text] [Related]
23. [High-dose chemotherapy with bone marrow transplantation in recurrent or refractory NHL].
Torello E; Koziner B
Sangre (Barc); 1993 Dec; 38(6):473-80. PubMed ID: 7909622
[No Abstract] [Full Text] [Related]
24. Impact of high-dose salvage therapy (BEAM) on overall survival in younger patients with advanced large-cell lymphomas entered into BNLI trials.
Linch DC; Vaughan Hudson B; Anderson L; Vaughan Hudson G
Ann Oncol; 1997; 8 Suppl 1():63-5. PubMed ID: 9187433
[TBL] [Abstract][Full Text] [Related]
25. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D
Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047
[TBL] [Abstract][Full Text] [Related]
26. Diffuse large B-cell lymphoma: is there a place for autologous hematopoietic stem cell transplant in first remission in the era of chemo-immunotherapy?
Nabhan C; Mehta J
Leuk Lymphoma; 2012 Oct; 53(10):1859-66. PubMed ID: 22448919
[TBL] [Abstract][Full Text] [Related]
27. Current therapeutic paradigm for the treatment of non-Hodgkin's lymphoma.
Fisher RI
Semin Oncol; 2000 Dec; 27(6 Suppl 12):2-8. PubMed ID: 11225996
[TBL] [Abstract][Full Text] [Related]
28. A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
Olivier G; Clavert A; Lacotte-Thierry L; Gardembas M; Escoffre-Barbe M; Brion A; Cumin I; Legouffe E; Solal-Celigny P; Chabin M; Ingrand P; Colombat P; Delwail V
Am J Hematol; 2014 Nov; 89(11):1024-9. PubMed ID: 25052698
[TBL] [Abstract][Full Text] [Related]
29. Cardiac lymphoma successfully treated with high dose chemotherapy followed by autologous haematopoietic stem cell transplantation.
Arimura K; Arima N; Hamada H; Kukita T; Matsushita K; Tei C
Haematologica; 2003 Dec; 88(12):ECR34. PubMed ID: 14688007
[No Abstract] [Full Text] [Related]
30. [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].
Hirose A; Yamane T; Nakajima Y; Manabe M; Kanashima H; Hagihara K; Sakamoto E; Nakamae M; Terada Y; Kosaka S; Aoyama Y; Sakamoto C; Kumura T; Koh KR; Hirai M; Ohta K; Nakao Y; Mugitani A; Teshima H; Hino M
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2059-64. PubMed ID: 16352929
[TBL] [Abstract][Full Text] [Related]
31. Durable remission of intravascular lymphoma with central nervous system involvement following chemotherapy and rituximab.
Go A; Venugopal P; Loew J; Djordjevic D
Clin Adv Hematol Oncol; 2006 Jun; 4(6):439-41. PubMed ID: 16981666
[No Abstract] [Full Text] [Related]
32. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N
Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
[TBL] [Abstract][Full Text] [Related]
33. [Monoclonal antibody therapy for malignant lymphoma].
Buske C; Dreyling M; Unterhalt M; Hiddemann W
Med Klin (Munich); 2005 Jan; 100(1):14-24. PubMed ID: 15654538
[TBL] [Abstract][Full Text] [Related]
34. [Malignant lymphoma].
Mori T
Gan To Kagaku Ryoho; 2007 Feb; 34(2):162-6. PubMed ID: 17301521
[TBL] [Abstract][Full Text] [Related]
35. Treatment of diffuse large B-cell lymphoma.
Coiffier B
Curr Hematol Rep; 2005 Jan; 4(1):7-14. PubMed ID: 15610654
[TBL] [Abstract][Full Text] [Related]
36. [Prognosis of primary non-Hodgkin's lymphoma of the breast].
Guo HY; Zhao XM; Cao JN; Hu XC; Yin JL; Hong XN; Li J
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):200-2. PubMed ID: 18756936
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of aggressive non-Hodgkin's lymphomas].
López A; Palacio C
Med Clin (Barc); 1998 May; 110(16):614-8. PubMed ID: 9656199
[No Abstract] [Full Text] [Related]
38. Diffuse large-cell lymphoma.
Fisher RI
Ann Oncol; 2000; 11 Suppl 1():29-33. PubMed ID: 10707775
[TBL] [Abstract][Full Text] [Related]
39. [Autologous transplant with BEAM protocol in lymphoma].
Caballero D; Rubio V; Rifon J; Heras I; García-Sanz R; Vidriales B; Pérez-Simón JA; del Cañizo C; González M; León A; Jean-Paul E; Rocha E; Vicente V; San Miguel JF
Sangre (Barc); 1997 Apr; 42 Suppl 1():46-9. PubMed ID: 9381303
[No Abstract] [Full Text] [Related]
40. [Lymphatic neoplasias in young patients].
Borchmann P; Gökbuget N; Wulf G; Trümper L
Onkologie; 2011; 34 Suppl 5():6-11. PubMed ID: 21921661
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]